Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 2 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 2 5 IN PLASTIC CONTAINER.
DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER vs DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intraperitoneal administration of dextrose creates an osmotic gradient that promotes ultrafiltration and removal of uremic toxins and excess fluid across the peritoneal membrane, while electrolytes in the solution correct imbalances.
Dextrose is a monosaccharide that serves as a caloric agent and increases osmotic pressure to facilitate ultrafiltration during peritoneal dialysis. The osmotic gradient created by dextrose drives the removal of waste products and excess fluid from the blood across the peritoneal membrane.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day, via continuous ambulatory peritoneal dialysis (CAPD).
Intraperitoneal administration: 2 L (or appropriate volume based on body size) infused over 10-20 minutes, dwell time 4-6 hours, then drain; typically 4 exchanges per 24 hours.
None Documented
None Documented
Not applicable (combination product); dextrose follows glucose kinetics (~1.5–2 h); electrolytes have no half-life.
Not applicable; dextrose is rapidly metabolized with a half-life of minutes; peritoneal dialysis dwell time is typically 4-6 hours.
Primarily renal; glucose is reabsorbed or metabolized; electrolytes follow renal handling. Not applicable as a drug; dialysate components are removed via peritoneal dialysis effluent.
Renal: 100% (dextrose is fully metabolized; water and electrolytes are removed via peritoneal dialysis, not excreted unchanged).
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution